In osteosarcoma, Gal-9 was found to be expressed in regulatory T cells (Tregs), and its interaction with Tim3+ T cells resulted in the suppression in Th1 responses, thus inhibit immune response [29]. Here, HAVCR2 is linked to osteosarcoma.